geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Multicenter, randomized trial comparing a combined gemcitabine and cisplatin 3-week regimen with a 4-week regimen in non-small cell lung cancer (NSCLC) patients


, : Multicenter, randomized trial comparing a combined gemcitabine and cisplatin 3-week regimen with a 4-week regimen in non-small cell lung cancer (NSCLC) patients. Journal of Clinical Oncology 24(18_suppl): 17062-17062

NlmCategory="UNASSIGNED">17062 Background: This multicenter, randomized Phase II study (B9E-GH-JHSE) was aimed to compare the efficacy and safety of a gemcitabine-cisplatin combination over a 3-week schedule versus a 4-week schedule as first line treatment for Chinese patients with advanced NSCLC. Patients (pts) with pathologically or histologically confirmed stage IIIB/IV NSCLC not amenable to curative surgery, and presenting at least one measurable lesion were eligible for this study. Pts were randomized to receive cisplatin (cis) 75 mg/m2 on Day 1 plus either gemcitabine (gem) 1250 mg/m2 on Day 1 and 8 of a 21-day cycle (3-week arm) or gem 1000 mg/m2 on Day 1, 8, and 15 of a 28-day cycle (4-week arm). Patients received up to 6 cycles of treatment during this study. The primary endpoint was WHO objective response rate (ORR) and secondary endpoints included time to progression (TTP), CTC toxicity, and overall survival. Of the 100 pts who were randomized to treatment, there were 51 pts in the 3-week arm: 14 females; mean age 59±8 yrs; 37% stage IIIB, 63% stage IV. In the 4-week arm, there were 49 pts: 24 females; mean age 56 ± 13 yrs; 33% stage IIIB, 67% stage IV. In the 3-week arm the overall response rate (complete response or partial response) was 24%, compared to 27% in the 4-week arm (Odds ratio: 1.17, 95% CI 0.47- 2.9, p = .819). There were no statistically significant differences between the two treatment arms in median overall survival time (3-week: 12.1 mths, 4-week: 13.8 mths; Hazard ratio (HR): 1.19, 95% CI 0.68-2.1, p = .54) and TTP (3-week: 4.9 mths, 4-week: 6.9 mths; HR: 1.33, 95% CI 0.85-2.1, p = .21). The difference in grade 3/4 hematological toxicities did not reach statistical significance (3-week: 37%, 4-week: 57%, p = .07), while grade 3/4 non-hematological toxicities were statistically significantly reduced in the 3-week arm (33% vs. 63%, p = .005). Grade 3/4 study drug related neutropenia (3-week: 27%, 4-week: 51%, p = .02) and thrombocytopenia (3-week: 8%, 4-week: 31%, p = .005) were reduced in the 3-week arm. While all efficacy endpoints were numerically superior in the 4-week arm, the difference was not statistically significant. However, grade 3/4 toxicities were reduced in the 3-week arm. [Table: see text].

US$29.90

PMID: 27953433


Other references

Girard, N., 2014: Evidence appraisal of Blandford CM, Gupta BC, Montgomery J, Stocker ME. Ability of patients to retain and recall new information in the post-anaesthetic recovery period: a prospective clinical study in day surgery. Anaesthesia. 2011;66(2): 1088-1092. Aorn Journal 99(2): 335-339

Glazovskiy N.F., 1975: Present-day problems of integrated studies on the processes of matter migration. Vestnik Moskovskogo Universiteta, Seriya 5: Geografiya 30(2): 27-35

Pan Y.W.; Dong J.J., 1991: Time-dependent tunnel convergence; I, Formulation of the model. International Journal of Rock Mechanics and Mining Sciences and Geomechanics Abstracts 28(6): 469-475

Cordery, D.V.; Cooper, D.A., 2011: Clinical research in NSW: its role in HIV care and prevention. Clinical research in NSW has contributed to some important breakthroughs in the understanding of many aspects for HIV transmission, pathogenesis and treatment. Researchers in NSW have played an important role in understanding the progression of HI...

Kere, J.; Palotie, L., 1996: About the effect of HUGO (Human Genome Project). Duodecim; Laaketieteellinen Aikakauskirja 112(4): 291-293

Saravanan, R.; Usha Sangeetha; Revathi, K., 2004: Effect of lindane toxicity in carbohydrate content of haemolymph, hepatopancreas and muscles of Penaeus indicus. A study was conducted to investigate the effect of lindane (0.02 ppm) on carbohydrate content of haemolymph, hepatopancreas and muscle tissues of male P. indicus (intermoult) and to analyse how the biochemical composition and metabolic process of...

Vanderveen, K.A.; Grant, C.S.; Thompson, G.B.; Farley, D.R.; Richards, M.L.; Vella, A.; Vollrath, B.; Service, F.John., 2011: Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycemia from diffuse islet cell disease. Noninsulinoma pancreatogenous hypoglycemia (NIPH) is a rare cause of hypoglycemia, especially affecting postbariatric surgery patients, related to excessive insulin secretion. Partial pancreatectomy controls hypoglycemia in the early postoperative...

Turner, J.Rick.; Kothari, S., 2015: Hypertension guidances published in 2013: a busy year with more to follow. Journal of Clinical Hypertension 16(4): 257-260

Anonymous, 1915: Educational Number, Sessions 1915-1916: The Profession Of Medicine. British Medical Journal 2(2853): 353-354

Aller, M.Isabel.; Paniagua, M.Angel.; Pollard, S.; Stephenson, F.Anne.; Fernandez-Lopez, A., 2003: The GABA(A) receptor complex in the chicken brain: immunocytochemical distribution of alpha 1- and gamma 2-subunits and autoradiographic distribution of BZ1 and BZ2 binding sites. Two antibodies, raised against the rat GABA(A) receptor alpha1- and gamma2-subunits, were used for an immunocytochemical study of the distribution of these proteins in the chicken brain. The immunoreactive bands obtained by Western blotting and th...